Bir Pediatrik Kutanöz Leishmaniasis Olgusu,

Yıl 2007, Cilt: 21 Sayı: 2, 97 - 101, 01.08.2007

D. Ölmez A. Babayiğit E. Kuşku N. Uzuner D. Alaygut S. Akarsu Ö. Karaman

Öz

Anahtar Kelimeler

-

Bir Pediatrik Kutanöz Leishmaniasis Olgusu

Öz

Leishmaniasis bazı kum sinekleri ile taşınan parazitik bir hastalıktır. Leishmania türleri
intrasellüler yerleşim göstererek farklı klinik tablolar oluşturlar. Bunlar kutanöz, visseral ve
mukokutanöz leishmaniasis olarak adlandırılır. Dünyanın bir çok bölgesinde endemik
enfeksiyon yapar. Kutanöz leishmaniasis, Türkiye’nin batı ve güneydoğu bölgelerinde endemik
olarak görülmektedir. Kliniği, parazit ve konak ile ilgili çeşitli faktörlere bağlı olarak
oldukça farklılık gösterebilmektedir.
Burada hastanemize başvurusundan iki yıl önce yüz bölgesinde ülseratif lezyonları ortaya
çıkan ve lezyondan yapılan direk yaymalarında leishmania amastigotları görülen iki buçuk
yaşındaki erkek hastayı sunduk.

Anahtar Kelimeler

Kutanöz leishmaniasis, çocuk

Kaynakça

• Memişoğlu HR, Kotoğyan A, Acar MA ve ark. Leish- maniasis. Tüzün Y, Kotoğyan A, Aydemir EH ve ark (eds): Dermatoloji, 2.baskı, Nobel Tıp Kitabevi, Istanbul, 1994; 221-231.
• van Eys GJJM, Schoone GJ, Lighthart GS, et al. Identification of world leishmania by DNA recombinant probes. Mol Biochem Parasitol 1989; 34: 53-62.
• Murray HW, Berman JD, Davies CR, Saravia NG. Avdan-ces in leishmaniasis. Lancet 2005;366:1561- 1577.
• Killick-Kendrick R. The biology and control of phlebo- tominesand flies. Clin Dermatol 1999;17: 279-289.
• http://www.who.int/mediacentre/factsheets/fs116/en/
• Alrajhi AA. Cutaneous Leishmaniasis of the Old World. Skin Therapy Lett 2003; 8:1-4.
• Zare S, Baghestani S. Cutaneous leishmaniasis in Hormozgan, Iran. Int J Dermatol 2001;40:629-631.
• Uzun S, Uslular C, Yucel A, et al. Cutaneous leish- maniasis: evaluation of 3074 cases in the Cukurova region of Turkey. Br J Dermatol 1999; 140: 347-350.
• Gurel MS, Ulukanligil M, Ozbilge H. Cutaneous leish- maniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000). Int J Dermatol 2002; 41:32-37.
• Gramiccia M, Bettini S, Yasarol S. Isoenzyme charac- terization of Leishmania isolates from human cases of cutaneous leishmaniasis in Urfa, south-east Turkey. Trans R Soc Trop Med Hyg 1984; 78: 568.
• Ozensoy S, Ozbel Y, Turgay N, et al. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 1998;59:363–369.
• Saylan T, Akbas A, Aydin R, et al. Sark cibaninda son yılların gözlemleri. TURKDERM 1986; 20: 47-50.
• Ozcel M, Ozbel Y, Ozensoy S, et al. The current status of leishmaniasis in Turkey. In: Matsumoto, Y, ed. Epide- miology and Control of Leishmaniasis in Central Eurasia. Research report Series No: 1 (1996 98). Tokyo: Interna- tional Press Editing Centre Incorporation, 1999; 27-30.
• Savk E, Sendur N, Karaman G. Cutaneous leishmaniasis in Aydin, Turkey. Int J Dermatol 1999; 38: 949-950.
• Aytekin S, Ertem M, Yagdiran O, Aytekin N. Clinico- epidemiologic study of cutaneous leishmaniasis in Diyarbakir Turkey. Dermatol Online J 2006;30;12:14.
• Pearson RD, Sousa AQ. Clinical spectrum of Leishma- niasis. Clin Infect Dis 1996;22: 11-13.
• Kafetzis DA. An overview of pediatric leishmaniasis. J Postgrad Med 2003;49: 31-38.
• Markele WH, Khaldoun MMO. Cutaneous leishmaniasis: Recognition and treatment. American Family Physician 2004;1-9.
• Samady JA, Schwartz RA. Old World cutaneousleish- maniasis. Int J Dermatol 1997; 36: 161-166.
• Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996;14: 417-423.
• http://www saglikx.com/index_dosyalar/ŞARKÇIBANI.htm
• Douba M, Mowakeh A, Wali A. Current status of cuta- neous leishmaniasis in Aleppo, Syrian Arab Republic. Bull World Health Organ, 1997; 75: 253-259.
• Kharfi M, Benmously R, El Fekih N, et al. Childhood leishmaniasis: report of 106 cases. Dermatol Online J 2004;10:6.
• de Brujin MH, Labrada LA, Smyth AJ, et al. A com- parativestudy of diagnosis by the polymerase chain reaction and bycurrent clinical methods using biopsies from Colombian patients with suspected leishmaniasis. Trop Med Parasitol 1993;44: 201–207.
• Belli A, Rodriguez B, Aviles H, et al. Simplified PCR detectionof new world Leishmaniain clinical specimens of cutaneousleishmaniasis. Am J Trop Med Hyg 1998;58: 102-109.
• Culha G, Uzun S, Ozcan K, Memisoglu HR, Chang KP. Comparison of conventional and polymerase chain reaction diagnostic techniques for leishmaniasis in the endemic region of Adana, Turkey. Int J Dermatol 2006; 45:569-572.
• Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment ofcutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004; 53: 158–166.
• Weina PJ, Neafie RC, Wortmann G, Polhemus M, Aronson NE. Old World leishmaniasis; an emerging infection among deployed US military and civilian workers. Clin Infect Dis 2004; 39: 1674-1680.
• No authors listed. Control of the leishmaniases. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1990;793:1-158.
• Uzun S, Durdu M, Culha G, Allahverdiyev AM, Memi- soglu HR. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey. J Parasitol 2004;90:853-859.
• Selim MM, Vlasin Z, Jaroskova L. Leishmaniasis. Cur- rently recommended treatment. Int J Dermatol 1990;29: 318-321.
• Ozgoztasi O, Baydar I. A randomized clinical trial of to- pical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int J Dermatol 1997; 36:61-63.
• Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol 1999;17: 305-315.